The other single-inhaler on the market for COPD triple therapy ... of analysis of other safety risks of triple therapy (e.g., oral thrush, osteoporosis, and adrenal insufficiency), the high ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market ...

The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

The causes of dyspneacan vary from physical exercise to pulmonary, car-diac ... Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment ...

When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems ...

Theochron (theophylline) is a medication used to manage severe asthma and chronic obstructive pulmonary disease ... decrease the absorption of oral osteoporosis medications like risedronate ...

Treprostinil Aids PAH Patients With Cardiovascular Issues Patients with pulmonary arterial hypertension and cardiovascular comorbidities may benefit from the use of inhaled or oral treprostinil as ...

typically prescribed orally to patients with COPD during exacerbations, increase HF.33 The discrepancy could be due to the systemic effects of oral corticosteroids at very high doses and over a short ...

Analyst Joseph Schwartz of Leerink Partners reiterated a Buy rating on Insmed (INSM – Research Report), with a price target of $85.00.Stay ...